The recall, which affects two models of Pipeline Vantage embolization devices, is linked to 17 injuries and four deaths.
Medtronic’s latest recall of the Pipeline Vantage 027 and 021 products is likely to result in revenue losses in the ...
The FDA announced that Medtronic initiated a device recall and correction for embolization devices. The FDA has identified ...
Shares of Medtronic (NYSE:MDT) reached a session low on Tuesday after the U.S. Food and Drug Administration (FDA) announced a product recall involving the company’s Pipeline Vantage 027 embolization ...
Medtronic has recalled certain Pipeline Vantage Embolization Devices with Shield Technology due to an increased risk of ...
Medtronic initiated the recall of certain Pipeline Vantage embolisation devices in January 2025 following reports of four ...
The FDA deemed a recall of some Medtronic Pipeline Vantage embolization devices serious after multiple deaths related to the ...
Medtronic will remove one model of Pipeline Vantage devices from where they’re used and sold and will update the instructions ...
The FDA recall affects more than 25,000 of the Fridley-run company’s devices and follows reports of 17 injuries.
The agency identified the recall as the most serious type. MDT’s Pipeline Vantage 027 devices are used to treat intracranial aneurysms. According to the FDA, the company has issued an urgent ...
In a notice posted to the agency’s website, the FDA noted that on January 30, 2025, Medtronic (MDT) Neurovascular sent all affected customers ...
The recall has two elements: Medtronic is removing from the market its Pipeline Vantage 027 devices, which are linked to most of the injuries and all of the deaths, and updating the instructions ...